IRS1 and type 2 diabetes mellitus: Proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-α) and IL-6, generated during the innate response, can inhibit insulin signaling through the phosphorylation of insulin receptor substrate 1 (IRS-1) [6, 7], serving to link inflammation with IR and type 2 diabetes [8].